Scarlet raises $50M Series B to speed up AI medical device certification

London-based Scarlet, a certification body for AI and software medical devices, raised $50 million in a Series B led by Headline. The company holds designations from the EU, the UK's MHRA and the US FDA, and aims to cut the 12–18 month certification backlog for AI medical devices.

• The $50M Series B was led by Headline
• Scarlet is the only one of ~52 EU bodies focused on software and AI
• AI medical device certification currently takes 12–18 months
• Customers include Flo Health, DeepHealth, NHS England and Skin Analytics